Previous Close | $18.46 |
Intrinsic Value | $0.00 |
Upside potential | -100% |
Data is not available at this time.
Sabra Health Care REIT, Inc. is a specialized real estate investment trust (REIT) focused on the healthcare sector, primarily owning and leasing skilled nursing, senior housing, and behavioral health facilities. The company generates revenue through long-term triple-net leases, where tenants cover property expenses, providing stable cash flows. Sabra operates in a niche segment of the healthcare real estate market, benefiting from demographic tailwinds such as an aging population and increasing demand for post-acute care services. Its portfolio is diversified across operators and geographies, mitigating concentration risk while maintaining a focus on high-quality assets. The REIT’s market position is strengthened by its disciplined capital allocation and partnerships with leading healthcare providers, ensuring occupancy stability and rent coverage. Sabra’s strategy emphasizes balance sheet strength and selective acquisitions to enhance portfolio quality and yield.
Sabra reported revenue of $703.2 million for FY 2024, with net income of $126.7 million and diluted EPS of $0.54. Operating cash flow stood at $310.5 million, reflecting strong cash generation from its lease-based model. The absence of capital expenditures highlights the REIT’s asset-light structure, where tenants bear maintenance costs. This efficiency supports consistent dividend distributions and reinvestment capacity.
The company’s earnings power is underpinned by its triple-net lease structure, which minimizes operational volatility. With $310.5 million in operating cash flow, Sabra demonstrates robust capital efficiency, translating into a cash flow yield that supports its dividend policy. The REIT’s focus on high-quality tenants and long-term leases enhances earnings stability, though sector-specific risks such as regulatory changes remain a consideration.
Sabra maintains a balanced financial position, with $60.5 million in cash and equivalents against $2.44 billion in total debt. The debt level is manageable given the REIT’s stable cash flows, though leverage metrics warrant monitoring. The absence of near-term maturities and access to diversified funding sources provide liquidity flexibility, supporting its investment-grade profile.
Growth is driven by strategic acquisitions and organic rent escalations, though the pace is tempered by sector headwinds. Sabra’s dividend of $1.20 per share reflects a payout ratio aligned with cash flow, offering a yield attractive to income-focused investors. The REIT’s disciplined capital recycling and focus on high-margin assets position it for sustainable growth.
The market values Sabra based on its stable cash flows and dividend yield, with a focus on occupancy trends and tenant health. Valuation multiples reflect sector risks, including reimbursement pressures and operator stability. Investor expectations hinge on Sabra’s ability to maintain rent coverage and navigate healthcare industry dynamics.
Sabra’s key advantages include its sector specialization, diversified tenant base, and conservative leverage. The outlook is cautiously optimistic, with growth opportunities in behavioral health and senior housing offsetting skilled nursing challenges. The REIT’s focus on operational resilience and strategic capital deployment positions it to capitalize on long-term demographic trends.
10-K, company filings
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |